Snapshot from Jul 27, 2026 at 07:00 UTC. For live data and tracking: View Live
Business stock option grant

Korro Bio grants stock options to new hires

Analysis based on 6 articles · First reported Jul 10, 2026 · Last updated Jul 10, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This is a routine corporate action with minimal market impact. It reflects standard hiring practices for a biopharmaceutical company.

biotechnology

Korro Bio, Inc. (Nasdaq: KRRO) announced the grant of non-statutory stock options to seven newly hired employees as an inducement material to their acceptance of employment, in accordance with Nasdaq Listing Rule 5635(c)(4). The options were granted under Korro's 2026 Inducement Plan, with four employees receiving options to purchase 6,000 shares at $10.59 per share and three employees receiving options to purchase 17,000 shares at $14.72 per share. The options have a ten-year term and vest over four years.

10 Korro Bio granted stock options
stock
Korro Bio granted stock options to new employees as an inducement for employment, a routine corporate action.
Importance 100.0 Sentiment 0.0
exch
Nasdaq is the exchange where Korro Bio is listed; the grants comply with Nasdaq Listing Rule 5635(c)(4).
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.